Abstract | INTRODUCTION: METHODS: We performed a retrospective analysis on 131 cardiac arrest survivors between 2007 and 2010, who underwent TH by femorally placed endovascular cooling catheter. All patients received prophylactic intravenous ampicillin-sulbactam for 72 hours to reduce the risk of aspiration pneumonia. Cooling catheter related CLABSI and other infections over a period of seven days from initiation of TH were estimated. RESULTS: Of a total 131 patients, 16 (12%) patients had bacteremia or infection prior to initiation of TH and were excluded. Of the remaining 115 (88%) patients, zero (0%) patients had cooling catheter related CLABSI and 23 (20%) patients had other infections during the study period. CONCLUSION: In cardiac arrest survivors undergoing TH, femorally placed endovascular cooling catheter is not associated with an increased incidence of CLABSI.
|
Authors | Nishant Patel, Sanjeev U Nair, Pampana Gowd, Ankur Gupta, David Morris, Giovanni G Geronilla, Justin Lundbye |
Journal | Connecticut medicine
(Conn Med)
Vol. 77
Issue 1
Pg. 35-41
(Jan 2013)
ISSN: 0010-6178 [Print] United States |
PMID | 23427372
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Bacterial Agents
- sultamicillin
- Ampicillin
- Sulbactam
|
Topics |
- Aged
- Ampicillin
(administration & dosage)
- Anti-Bacterial Agents
(administration & dosage)
- Catheter-Related Infections
(drug therapy, etiology)
- Catheterization, Central Venous
(adverse effects, methods)
- Cross Infection
(drug therapy, etiology)
- Endovascular Procedures
- Female
- Heart Arrest
(therapy)
- Humans
- Hypothermia, Induced
(methods)
- Male
- Middle Aged
- Retrospective Studies
- Sepsis
(drug therapy, etiology)
- Sulbactam
(administration & dosage)
|